Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech medical study

Melatonin long-term use heart failure risk

Analysis based on 6 articles · First reported Aug 29, 2026 · Last updated Sep 09, 2026

Sentiment
-10
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The study may raise concerns about the safety of long-term melatonin use, potentially affecting consumer behavior and sales of melatonin supplements. However, since the findings are preliminary and not causal, the impact on supplement manufacturers is likely limited in the short term.

Pharmaceuticals Healthcare

A preliminary study presented at the American Heart Association's Scientific Sessions 2025 found that adults with chronic insomnia who used melatonin for at least 12 months had about a 90% higher risk of developing heart failure over five years compared to non-users. The study, based on data from the TriNetX Global Research Network, analyzed over 130,000 adults with insomnia. Heart failure occurred in 4.6% of melatonin users versus 2.7% of non-users. Melatonin users were also nearly 3.5 times more likely to be hospitalized for heart failure and had higher all-cause mortality (7.8% vs 4.3%). The findings are observational and do not prove causation. Researchers noted limitations including potential misclassification of over-the-counter users and unmeasured factors like insomnia severity. A separate NHANES analysis did not find a significant link, and a review of clinical trials showed mixed effects. Experts urge caution against long-term use without medical indication.

ngo
The AHA hosted the Scientific Sessions where the study was presented, highlighting its role in disseminating cardiovascular research.
Importance 60.0 Sentiment 10.0
per
Lead author of the study; his findings raise safety questions about melatonin, potentially influencing clinical guidance.
Importance 50.0 Sentiment 0.0
priv
Provided the data for the study; its database is a key resource for medical research.
Importance 40.0 Sentiment 10.0
oth
Affiliation of the lead author; the study adds to its research portfolio.
Importance 30.0 Sentiment 0.0
per
Expert commentator who expressed surprise at long-term melatonin use, reinforcing caution.
Importance 30.0 Sentiment 0.0
cnt
Regulatory context: melatonin is an over-the-counter supplement, leading to potential misclassification in the study.
Importance 30.0 Sentiment 0.0
cnt
Regulatory context: melatonin requires prescription, affecting study design and interpretation.
Importance 20.0 Sentiment 0.0
ngo
Mentioned as offering practical advice on reducing melatonin use; not directly impacted.
Importance 10.0 Sentiment 0.0
United States allies ↔ United Kingdom The United States considers the United Kingdom a vital defense ally and significant economic partner, relying on its str
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.